Siciliano, Massimo
 Distribuzione geografica
Continente #
EU - Europa 2.108
NA - Nord America 1.932
AS - Asia 662
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
OC - Oceania 3
Totale 4.732
Nazione #
US - Stati Uniti d'America 1.919
DE - Germania 939
SE - Svezia 402
CN - Cina 298
UA - Ucraina 203
SG - Singapore 181
IT - Italia 159
IE - Irlanda 100
FR - Francia 82
GB - Regno Unito 78
FI - Finlandia 64
ID - Indonesia 58
TR - Turchia 39
IN - India 38
RU - Federazione Russa 32
BE - Belgio 22
IR - Iran 21
HK - Hong Kong 15
CA - Canada 12
CI - Costa d'Avorio 12
EU - Europa 8
GR - Grecia 5
BR - Brasile 4
JP - Giappone 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
LT - Lituania 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
MK - Macedonia 2
NL - Olanda 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
KW - Kuwait 1
MU - Mauritius 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.732
Città #
Chandler 469
Singapore 147
Ashburn 135
Jacksonville 120
San Mateo 104
Dublin 99
Ann Arbor 74
Nürnberg 62
Jakarta 58
New York 58
Wilmington 58
Cattolica 57
Nanjing 57
Boston 46
Dearborn 46
Woodbridge 39
Izmir 38
Marseille 32
Princeton 32
Redwood City 31
Helsinki 28
Beijing 27
Bremen 26
Nanchang 26
Zhengzhou 25
Moscow 24
Munich 24
Lawrence 23
Brussels 22
Houston 20
Hangzhou 19
Lancaster 19
Leawood 19
Andover 18
Augusta 18
Hebei 17
Tianjin 17
Seattle 16
Shenyang 15
Boardman 14
Fairfield 13
Rome 13
Abidjan 12
Changsha 12
Falls Church 12
Kunming 11
Los Angeles 11
Norwalk 10
University Park 10
Milan 9
Hong Kong 8
Kish 8
Shanghai 8
Bologna 7
Frankfurt am Main 7
Jiaxing 7
London 7
Mountain View 7
Detroit 6
Guangzhou 6
Jinan 6
Mcallen 6
Ardabil 5
Cambridge 5
Falkenstein 5
San Diego 5
Toronto 5
Athens 4
Hounslow 4
Las Vegas 4
Ningbo 4
Ottawa 4
Santa Clara 4
Zanjan 4
Chicago 3
Costa Mesa 3
Fremont 3
Phoenix 3
Pune 3
Sacramento 3
San Jose 3
Albuquerque 2
Bioggio 2
Busto Arsizio 2
Changchun 2
Dubai 2
Grumo Nevano 2
Harbin 2
Hefei 2
Köln 2
Montréal 2
Nagold 2
Nardò 2
Paris 2
Portland 2
Redmond 2
San Francisco 2
Skopje 2
Stockholm 2
São Paulo 2
Totale 2.487
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 217
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 184
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 158
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 153
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 145
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 140
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 125
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 118
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 112
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 106
Model for end-stage liver disease dynamic stratification of survival benefit 104
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 103
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 100
Microscopic colitis 100
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 100
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 94
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 93
Liver transplantation in patients with alcoholic liver disease: A retrospective study 93
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 92
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 92
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 92
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 90
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 86
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 83
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 82
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 81
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 79
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 78
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 77
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 76
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 71
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 68
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 68
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 67
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 64
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 64
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 63
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 63
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 62
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 61
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 61
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 60
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 57
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 56
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 55
Regorafenib: a promising treatment for hepatocellular carcinoma 55
The new era of hepatitis C treatment: still the tip of the iceberg? 53
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 53
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 49
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 43
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 41
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 40
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 36
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 35
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 34
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 31
Totale 4.803
Categoria #
all - tutte 19.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020415 0 0 0 0 0 60 81 26 63 56 76 53
2020/2021476 30 43 7 44 58 29 48 11 58 33 99 16
2021/2022598 37 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/2025293 16 34 84 23 111 25 0 0 0 0 0 0
Totale 4.803